Shuttle Pharmaceuticals
Manufacturing Ā· Maryland, United States Ā· 1-10 Employees
View Company Info for Free
Overview
Headquarters
401 Professional Dr Ste 260, Gaithersbur...Phone Number
(240) 430-4212Website
www.shuttlepharma.comRevenue
-Stock Symbol
SHPHIndustry
About Shuttle Pharmaceuticals
Shuttle Pharmaceuticals Org Chart
Is Shuttle Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Shuttle Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Shuttle Pharmaceuticals has new funding data
Earning: See what the market has to say on Shuttle Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Shuttle Pharmaceuticals
Check if Shuttle Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Shuttle Pharmaceuticals is spiking on competitors!
Click to see if Shuttle Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Shuttle Pharmaceuticals launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Shuttle Pharmaceuticals
Compare insights from companies similar to Shuttle Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Shuttle Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Shuttle Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Shuttle Pharmaceuticals.
Shuttle Pharmaceuticals financials insights
Gather financial insights about Shuttle Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$73K
Other Financing Round
$790K
Shuttle Pharmaceuticals Tech Stack
A closer look at the technologies used by Shuttle Pharmaceuticals
Most Recent Scoops
Shuttle Pharmaceuticals News & Media
Shuttle Pharmaceuticals to Acquire United Dogecoin; Adds $11 Million PIPE and Amends Prior Deal
Shuttle Pharmaceuticals announced multiple material agreements, led by a definitive merger to acquire United Dogecoin in a stock-for-stock transaction expected to close on May 4, 2026. To support the transaction and growth, the company entered a $11.0 million PIPE issuing Series B-2 preferred stockā¦Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner
Gaithersburg, Maryland--(Newsfile Corp. - April 30, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive...Timothy Lorber Resigns As CFO Of Shuttle Pharmaceuticals - SEC Filing - TradingView
Shuttle Pharmaceuticals Holdings Inc NASDAQ:SHPH:Shuttle Pharmaceuticals Raises $2.5 Million in Private Placement - TipRanks.com
An announcement from Shuttle Pharmaceuticals Holdings, Inc. ( ($SHPH) ) is now available. On November 3, 2025, Shuttle Pharmaceuticals Holdings, Inc. entered into a...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Shuttle Pharmaceuticals
Shuttle Pharmaceuticals is a clinicalstage specialty pharmaceutical company dedicated to improving treatment outcomes for cancer patients undergoing radiation therapy. It develops novel therapeutic drugs and diagnostic tools designed to make radiation therapy more effective and less harmful: some of its lead candidates aim to sensitize cancer cells... Read More